BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2407565)

  • 1. Luteal support after luteinizing hormone-releasing hormone agonist for in vitro fertilization: superiority of human chorionic gonadotropin over oral progesterone.
    Buvat J; Marcolin G; Guittard C; Herbaut JC; Louvet AL; Dehaene JL
    Fertil Steril; 1990 Mar; 53(3):490-4. PubMed ID: 2407565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteal phase support for assisted reproduction cycles.
    van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
    Cochrane Database Syst Rev; 2011 Oct; (10):CD009154. PubMed ID: 21975790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist.
    Schmidt-Sarosi C; Kaplan DR; Sarosi P; Essig MN; Licciardi FL; Keltz M; Levitz M
    J Assist Reprod Genet; 1995 Mar; 12(3):167-74. PubMed ID: 8520180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The benefits of mid-luteal addition of human chorionic gonadotrophin in in-vitro fertilization using a down-regulation protocol and luteal support with progesterone.
    Herman A; Raziel A; Strassburger D; Soffer Y; Bukovsky I; Ron-El R
    Hum Reprod; 1996 Jul; 11(7):1552-7. PubMed ID: 8671503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteal rescue in in vitro fertilization-embryo transfer.
    Hutchinson-Williams KA; DeCherney AH; Lavy G; Diamond MP; Naftolin F; Lunenfeld B
    Fertil Steril; 1990 Mar; 53(3):495-501. PubMed ID: 2307247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of gonadotrophin-releasing hormone agonists administered as desensitizing or flare protocols on hormonal function in the luteal phase of hyperstimulated cycles.
    Norman RJ; Warnes GM; Wang X; Kirby CA; Matthews CD
    Hum Reprod; 1991 Feb; 6(2):206-13. PubMed ID: 1905309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone.
    Claman P; Domingo M; Leader A
    Hum Reprod; 1992 Apr; 7(4):487-9. PubMed ID: 1522190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins.
    Herman A; Ron-El R; Golan A; Raziel A; Soffer Y; Caspi E
    Fertil Steril; 1990 Jan; 53(1):92-6. PubMed ID: 2104811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human chorionic gonadotropin and intravaginal natural progesterone are equally effective for luteal phase support in IVF.
    Martinez F; Coroleu B; Parera N; Alvarez M; Traver JM; Boada M; Barri PN
    Gynecol Endocrinol; 2000 Oct; 14(5):316-20. PubMed ID: 11109970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilization.
    Segal S; Casper RF
    Fertil Steril; 1992 Jun; 57(6):1254-8. PubMed ID: 1601147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction.
    Araujo E; Bernardini L; Frederick JL; Asch RH; Balmaceda JP
    J Assist Reprod Genet; 1994 Feb; 11(2):74-8. PubMed ID: 7819706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.
    Penzias AS; Shamma FN; Gutmann JN; Seifer DB; DeCherney AH; Lavy G
    J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human chorionic gonadotropin combined with progesterone for luteal support improves pregnancy rate in patients with low late-midluteal estradiol levels in IVF cycles.
    Fujimoto A; Osuga Y; Fujiwara T; Yano T; Tsutsumi O; Momoeda M; Kugu K; Koga K; Morita Y; Wada O; Taketani Y
    J Assist Reprod Genet; 2002 Dec; 19(12):550-4. PubMed ID: 12503886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luteal-phase support in stimulated cycles in an in vitro fertilization/embryo transfer program: progesterone versus human chorionic gonadotropin.
    Nader S; Berkowitz AS; Ochs D; Held B; Winkel CA
    J In Vitro Fert Embryo Transf; 1988 Apr; 5(2):81-4. PubMed ID: 3411179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chorionic gonadotropin support of the luteal phase following in vitro fertilization and embryo transfer. Randomized comparison with oral progesterone in protocols using triptoreline].
    Buvat J; Marcolin G; Guittard C; Dehaene JL; Verbecq P; Renouard O; Herbaut JC; Louvet AL
    Presse Med; 1989 Mar; 18(10):539. PubMed ID: 2523046
    [No Abstract]   [Full Text] [Related]  

  • 18. Desensitization of both luteal and pituitary function in baboons with nafarelin, a potent LH-RH agonist.
    Vickery BH; Powell J; Stevens VC
    Int J Fertil; 1988; 33(3):188-93. PubMed ID: 2899565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study.
    Pirard C; Donnez J; Loumaye E
    Hum Reprod; 2006 Jul; 21(7):1894-900. PubMed ID: 16556673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of human chorionic gonadotropin support following in vitro fertilization and embryo transfer.
    Buvat J; Marcolin G; Herbaut JC; Dehaene JL; Verbecq P; Fourlinnie JC
    Fertil Steril; 1988 Mar; 49(3):458-61. PubMed ID: 3277865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.